Genomtec S.A. (WSE:GMT)
Poland
· Delayed Price · Currency is PLN 4.700
-0.075 (-1.57%)
Apr 28, 2026, 5:03 PM CET
Genomtec Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 0.02 | 0 | 0 | 0.04 | 0.22 | 0.02 |
| Revenue Growth (YoY) | 1400.00% | - | -97.50% | -81.73% | 995.00% | - |
| Cost of Revenue | 8.13 | 4.31 | 0.79 | 3.27 | 5.38 | 3.53 |
| Gross Profit | -8.12 | -4.31 | -0.79 | -3.23 | -5.16 | -3.51 |
| Selling, General & Admin | 5.53 | 9.14 | 9.43 | 8.57 | 5.36 | 10.97 |
| Other Operating Expenses | -2.86 | -2.39 | -1.41 | -0.31 | -3.53 | -3.62 |
| Operating Expenses | 2.68 | 6.76 | 8.02 | 8.26 | 1.83 | 7.36 |
| Operating Income | -10.79 | -11.06 | -8.82 | -11.49 | -7 | -10.86 |
| Interest Expense | -0.28 | -0.13 | -0.12 | -0.2 | -0.03 | -0.02 |
| Interest & Investment Income | 0.08 | 0.07 | 0.06 | - | - | 0 |
| Currency Exchange Gain (Loss) | -0.07 | -0.07 | -0.13 | -0.1 | -0.09 | -0.06 |
| Other Non Operating Income (Expenses) | -0 | -0 | -0.12 | -0.09 | - | -0 |
| EBT Excluding Unusual Items | -11.07 | -11.2 | -9.12 | -11.88 | -7.11 | -10.94 |
| Gain (Loss) on Sale of Assets | - | 0.01 | 0.08 | - | - | - |
| Asset Writedown | 0 | 0 | 0 | - | - | - |
| Pretax Income | -11.06 | -11.19 | -9.03 | -11.88 | -7.11 | -10.94 |
| Income Tax Expense | -0.05 | 0.02 | -0.02 | 0.05 | 0.01 | 0 |
| Net Income | -11.01 | -11.21 | -9.01 | -11.93 | -7.12 | -10.94 |
| Net Income to Common | -11.01 | -11.21 | -9.01 | -11.93 | -7.12 | -10.94 |
| Shares Outstanding (Basic) | 15 | 13 | 12 | 9 | 8 | 8 |
| Shares Outstanding (Diluted) | 15 | 13 | 12 | 9 | 8 | 8 |
| Shares Change (YoY) | 9.56% | 8.70% | 30.90% | 14.78% | - | - |
| EPS (Basic) | -0.75 | -0.84 | -0.74 | -1.27 | -0.87 | -1.34 |
| EPS (Diluted) | -0.75 | -0.84 | -0.74 | -1.27 | -0.87 | -1.34 |
| Free Cash Flow | -7.92 | -6.78 | -11.48 | -7.93 | -5.71 | -2.63 |
| Free Cash Flow Per Share | -0.54 | -0.51 | -0.94 | -0.85 | -0.70 | -0.32 |
| Operating Margin | -71960.00% | -1106400.00% | -881500.00% | -28730.00% | -3194.06% | -54315.00% |
| Profit Margin | -73393.33% | -1120800.00% | -901300.00% | -29820.00% | -3248.86% | -54695.00% |
| Free Cash Flow Margin | -52780.00% | -677500.00% | -1147900.00% | -19822.50% | -2608.68% | -13135.00% |
| EBITDA | -8.06 | -8.73 | -7.66 | -11.06 | -6.49 | -10.62 |
| D&A For EBITDA | 2.73 | 2.33 | 1.16 | 0.44 | 0.5 | 0.24 |
| EBIT | -10.79 | -11.06 | -8.82 | -11.49 | -7 | -10.86 |
Source: S&P Capital IQ. Standard template. Financial Sources.